Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has received approval from the USFDA ...

Bafna Pharmaceuticals Limited ("The Company") has been honored with the "Emerging Company of the Year in Healthcare" award at ...

Alnylam Pharmaceuticals said its RNAi therapeutic vutrisiran received a positive opinion recommending approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency.

ingapore's deputy prime minister said the city-state is negotiating concessions for pharmaceutical exports to the United States after a call with US Commerce Secretary Howard Lutnick. Gan Kim Yong ...

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

Big Pharma isn’t sure how to handle Donald Trump’s Republican Party. Trump is pledging to impose tariffs on drug imports, while Health Secretary Robert F. Kennedy Jr. has vilified the drug ...

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the sector, which pharma giant Pfizer privately warned could damage the Irish ...

There are 64 manufacturing sites operated by Thermo Fisher in the US that provide contract development and manufacturing services for pharmaceutical innovators. Facilities also make analytical ...

Mumbai: The Indian pharmaceutical and healthcare sector experienced a sharp 70 per cent decline in deal values during the first quarter of Calendar Year 2025, with transactions totaling $2.1 ...

Read also: Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues Earlier in April, Lupin Healthcare (UK) Limited acquired Renascience Pharma Limited, a UK-based ...

Indian pharmaceutical firms can explore opportunities in regions such as Europe, Africa, and Latin America, focusing on high-margin products while optimizing their supply chains. Trump has ...